Kumar, KartikPonnuswamy, AravindCapstick, Toby GdChen, ChristabelleMcCabe, DouglasHurst, RhysMorrison, LisaMoore, FionaGallardo, MattKeane, JennieHarwood, ShirleySinnett, TanyaBryant, SarahBreen, RonanKon, Onn MinLipman, MarcLoebinger, Michael R.Dhasmana, Devesh J.2024-03-072024-03-072024-01-17Kumar, K., Ponnuswamy, A., Capstick, T. G., Chen, C., McCabe, D., Hurst, R., Morrison, L., Moore, F., Gallardo, M., Keane, J., Harwood, S., Sinnett, T., Bryant, S., Breen, R., Kon, O. Min., Lipman, M., Loebinger, M. R., & Dhasmana, D. J. (2024). Non-tuberculous mycobacterial pulmonary disease (NTM-PD): Epidemiology, diagnosis and multidisciplinary management. Clinical Medicine, 24(1), article-number 100017. https://doi.org/10.1016/j.clinme.2024.1000171470-211810.1016/j.clinme.2024.100017http://hdl.handle.net/10034/628527Non-tuberculous mycobacteria (NTM) are ubiquitous environmental organisms that can cause significant disease in both immunocompromised and immunocompetent individuals. The incidence of NTM pulmonary disease (NTM-PD) is rising globally. Diagnostic challenges persist and treatment efficacy is variable. This article provides an overview of NTM-PD for clinicians. We discuss how common it is, who is at risk, how it is diagnosed and the multidisciplinary approach to its clinical management. [Abstract copyright: Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.]https://creativecommons.org/licenses/by-nc-nd/4.0/HumansNontuberculous MycobacteriaNon-tuberculous mycobacteriaPulmonary diseaseMultidisciplinary managementDiagnosisEpidemiologyImmunocompromised HostArticleClinical Medicine2024-03-07